Deutsche Bank unit fined $25M in ESG, AML settlements
By 
Kyle Brasseur2023-09-25T17:26:00
The asset management arm of Deutsche Bank agreed to pay $25 million in penalties across two separate settlements with the Securities and Exchange Commission (SEC) addressing alleged misstatements in environmental, social, and governance (ESG) investments and anti-money laundering (AML) violations.
DWS Investment Management Americas was fined $19 million as part of the ESG action and $6 million for the AML lapses, the SEC announced in a press release Monday.
Deutsche Bank has been no stranger to punishment over its AML controls, while the ESG matter received notable attention last year after then-DWS Chief Executive Asoka Woehrmann announced his resignation amid an investigation by German officials into allegations of greenwashing.
Related articles
-
News BriefDeutsche Bank dinged $54K over IT incident reporting
Deutsche Bank was assessed a penalty of €50,000 (U.S. $54,000) by Germany’s financial supervisory authority for its alleged miscommunication of a 2023 information technology security incident.
-
PremiumDeutsche Bank unit ESG fine less about greenwashing, more about disclosures
The $19 million fine against DWS Investment Management Americas levied by the SEC wasn’t to punish greenwashing, experts said, but rather a penalty imposed for the firm not doing what it claimed related to its environmental, social, and governance investment strategy.
-
News BriefShinhan Bank America fined $25M for repeat AML compliance failures
The American branch of South Korea-based Shinhan Bank agreed to pay $25 million across settlements with three separate regulators for admitted violations of the Bank Secrecy Act and anti-money laundering requirements.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”